Addressing research gaps: The UK’s efforts to study lung cancer in never smokers

FHS
July 25, 2023
9:10 am

Study aimed to understand the specific needs of lung cancer in never smokers (LCINS) patients.

Bayer and MOMA Therapeutics partner for oncology programme

Bayer will oversee the programme’s progression through further preclinical development and potential commercialisation. Credit: Lightspring/Shutterstock. Bayer has entered a strategic collaboration with MOMA Therapeutics to

October 8, 2024

StemSight and ERS Genomics focus on collaboration

License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in development of cell therapies for corneal blindness.

January 17, 2024

Aldeyra and AbbVie partner for reproxalap development

AbbVie has the option to obtain a co-exclusive licence for reproxalap’s development, manufacture and commercialisation in the US. Credit: Valeriya Zankovych / Shutterstock.com. Aldeyra Therapeutics

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.